Destruxins (dtx) A, B, and E, showing a variety of biological activities, are the main toxic secondary metabolites of the entomopathogenous ascomycete Metarhizium anisopliae Bipesco 5, a widely used biocontrol production strain. Dynamics of dtx biosynthesis were monitored during liquid fermentation in a chemically defined medium. During shake flask cultivation with excess carbon, nitrogen and phosphate, approximately 50, 20, and 100 mg l(-1) dtx A, B, and E were produced after 12 d. Destruxins were produced during exponential growth phase and in the stationary phase. Carbon exhaustion in the culture broth was demonstrated to affect destruxin production to a minor degree: Absolute dtx amounts in the liquid increased also after glucose exhaustion; dtx amounts referred to biomass increased further evidently in shake flasks or slightly in bioreactor experiments after carbon limitation occurred. Contrarily, nitrogen exhaustion resulted in an evident decline in dtx amounts referred to biomass. Absolute amounts in the culture broth, however, still increased slightly the following four days in bioreactor experiments. From this we conclude that dtx production is highly influenced by nitrogen availability. Generally, dtx production in bioreactors with controlled aeration (1 vvm) was significantly lower than in shake flasks.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jobm.200800332DOI Listing

Publication Analysis

Top Keywords

dtx amounts
12
destruxin production
8
metarhizium anisopliae
8
carbon nitrogen
8
nitrogen exhaustion
8
dtx
8
culture broth
8
amounts referred
8
referred biomass
8
shake flasks
8

Similar Publications

Article Synopsis
  • Effective targeting using nano drug delivery systems (NDDS) helps deliver medications directly into cancer cells, improving treatment efficiency by overcoming cellular defenses.
  • The study developed a dual-responsive nanoparticle system loaded with the chemotherapy drug DTX that activates specifically in the tumor environment, leading to a significant release of the drug.
  • In tests, the new formulation showed 5 times greater cytotoxicity compared to free DTX, effectively inhibiting tumor growth in mice with lower doses, indicating a promising advancement in cancer treatment strategies.
View Article and Find Full Text PDF

Interleukin-17A (IL-17A) is involved in antibody specificity to conformational epitopes.

Biochem Biophys Res Commun

December 2024

Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia y Bioquímica, Buenos Aires, Argentina. Electronic address:

The specificity of antibodies (Ab) is essential for the precise recognition of foreign or dangerous molecules. We have shown that mice infected with non-pathogenic Lactate Dehydrogenase Elevating Virus (LDV) inoculated with human growth hormone (hGH) or Ovalbumin (OVA), exhibit modified specificity of anti-hGH or anti-OVA Ab associated with the secretion of IFN-γ, IL-13, and IL-17. Cytokines are directly or indirectly involved in the isotypes, specificity, and affinity of Ab.

View Article and Find Full Text PDF
Article Synopsis
  • Many patients with metabolic dysfunction-associated steatotic liver disease struggle to lose weight using traditional in-person methods, prompting interest in digital therapeutic (DTx) options that may overcome these limitations.
  • * A review of studies showed that DTx lifestyle interventions resulted in an average body weight loss of 3.4 kg and a significant rate of clinically meaningful weight loss (≥5%) in 33% of participants over various durations.
  • * DTx interventions not only led to more effective weight loss compared to standard care but also contributed to improvements in liver enzyme levels, suggesting a valuable approach for a large population affected by this condition.*
View Article and Find Full Text PDF

Docetaxel (DTX) chemotherapy is commonly used in the treatment of patients with advanced prostate cancer demonstrating modest improvements in survival. As these patients are often elderly and the chemotherapy treatment is not targeted, it is often poorly tolerated. More targeted approaches that increase therapeutic efficacy yet reduce the amount of toxic chemotherapy administered are needed.

View Article and Find Full Text PDF

Lung cancer is currently the most prevalent cause of cancer mortality due to late diagnosis and lack of curative therapies. Docetaxel (Dtx) is clinically proven as effective, but poor aqueous solubility and non-selective cytotoxicity limit its therapeutic efficacy. In this work, a nanostructured lipid carrier (NLC) loaded with iron oxide nanoparticles (IONP) and Dtx (Dtx-MNLC) was developed as a potential theranostic agent for lung cancer treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!